J D O'Sullivan. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/administration & dosageAntiparkinson Agents/pharmacologyApomorphine/administration & dosageApomorphine/pharmacologyErectile Dysfunction/drug therapyHumansInjections, SubcutaneousMaleMultiple System Atrophy/complicationsParkinson Disease/complicationsPhosphodiesterase Inhibitors/administration & dosagePhosphodiesterase Inhibitors/pharmacologyPiperazines/administration & dosagePiperazines/pharmacologyPurinesSildenafil CitrateSulfones
Substances: See more » Antiparkinson AgentsPhosphodiesterase InhibitorsPiperazinesPurinesSulfonesSildenafil CitrateApomorphine
Year: 2002 PMID: 11971072 PMCID: PMC1737862 DOI: 10.1136/jnnp.72.5.681
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154